Pakistan continues to be dealing with a polio outbreak as four fresh cases have emerged, pushing the national tally to 37 this year, according to health officials on October 19, 2024. Health officials said that the regional reference laboratory for polio eradication at the National Institute of Health in Islamabad confirmed wild poliovirus type-1 (WPV1) in two children-one from each Balochistan and Khyber-Pakhtunkhwa.

In recent cases, a girl has been affected from Pishin, and two boys from Chaman and Noshki of Balochistan, and a girl from Lakki Marwat in KP. These are the first detections of the virus within Noshki and Lakki Marwat this year; isolated cases of poliovirus were previously reported within Chaman and Pishin. The province of Balochistan was the worst hit with 20 cases, Sindh had 10, Khyber Pakhtunkhwa had five, and Punjab and Islamabad had one case each.

A gigantic fight against polio has been on going in Pakistan- especially in Balochistan and southern KP-over the last two years. Immunisation campaigns have often been suspended or delayed because of local protests, insecurity, and community boycotts. Consequently, quite a number of children did not get the necessary vaccinations, making existing patches of vulnerability for the virus to flow within those pockets.

Noshki, located near Afghanistan's border, and Lakki Marwat have also recently reported some positive environmental samples that confirm the virus is present here, said a local reference laboratory official. Samples of latest cases are currently under genetic sequencing for checking spread of virus and origin.

As the threat of polio continues to grow, Pakistan has vowed to mount a nationwide campaign against it beginning from October 28. With the zeal to tackle the menace in the most effective manner, over 45 million children under the age of five will be vaccinated across the country.

Today, Afghanistan and Pakistan remain one of the few countries where polio has not yet been eradicated. The WHO said the virus remains a potential serious public health threat in areas with low vaccination coverage and weak surveillance.

India On Alert Against Polio

The country declared itself polio-free since 2014 and has kept the disease on bay almost a decade with very robust vaccination programs; however, two cases of vaccine-derived poliovirus cases reported in recent days from Meghalaya create some amount of doubts over a possible resurgence. Experts observe that in India, despite these detections taking place, strong coverage of vaccination at 90-95% and mandatory surveillance measures keep the risk of this widespread outbreak at bay.

The experts point out, however, that such stable situation in India requires continued surveillance. "Countries like Pakistan and parts of Africa remain at a high risk because vaccination rates in those areas are much lower," Dr. Siddharth, public health expert, said. Vaccination is an indispensable act in order to avoid the spread of this incapacitating disease that manifests most importantly as a nervous system affliction leading to the paralysis of a long period.

With concerted efforts from health authorities, there is hope someday that the scourge of polio will be completely eradicated from the face of the earth and future generations will never suffer from its effects.

A sudden and unusually early rise in norovirus infections, often called the “winter vomiting disease”, has been reported across the United States, adding yet another health concern to a season already crowded with respiratory illnesses, as noted by Axios. Figures from the Centers for Disease Control and Prevention (CDC) show that positive norovirus tests have doubled over recent weeks, climbing from seven percent in August to 14 percent by mid-November.

This spike has arrived sooner than expected and at a time when cases of COVID, whooping cough, and seasonal flu are also climbing.

Winter Vomiting Disease: What Is The Norovirus?

Norovirus leads to intense vomiting and diarrhea because it irritates the stomach and intestines, as described by the CDC. This has earned it the informal name “extreme vomiting disease.”

It is the most frequent cause of vomiting and diarrhea in the country. Nearly 20 million people deal with norovirus each year, according to Scientific American. It is different from the common “stomach bug” or “stomach flu” and has no link to the influenza virus.

Winter Vomiting Disease: Norovirus Symptoms To Watch For

Symptoms typically appear 12 to 48 hours after exposure and often include:

• Diarrhea
• Vomiting
• Nausea
• Stomach pain
• Dehydration (usually due to repeated vomiting and diarrhea)

Less often, people may also experience fever, headaches, or body aches.

Winter Vomiting Disease: Who Is At Risk For Norovirus?

Norovirus outbreaks can affect anyone, but children and older adults face a higher chance of serious illness, the CDC notes. Since several strains of the virus exist, people may get sick more than once. Genetics may also influence how likely someone is to catch it.

Winter Vomiting Disease: How Does Norovirus Spread?

Health officials describe norovirus as extremely contagious. It spreads quickly through droplets, contaminated surfaces, or unsafe food.

Norovirus is a human virus usually spread through the fecal-oral route,” explained Robyn Chatman, a Cincinnati physician, to the American Medical Association. This means the virus can transfer from contaminated hands to the mouth during routine activities. It can remain on surfaces for days or even weeks and moves rapidly in crowded places such as nursing homes, child care centers, and cruise ships, the AMA notes.

Winter Vomiting Disease: Why Are Norovirus Cases Spreading In The US?

A norovirus “outbreak,” as defined by the CDC, occurs when two or more similar illnesses stem from the same suspected or confirmed source. The CDC records about 2,500 such outbreaks each year.

Between August 1 and November 13, 153 outbreaks were reported. By comparison, only 69 outbreaks had been recorded by the final week of November last year. In early December 2023, the U.S. logged 65 outbreaks, according to AP.

Everyday Health reports that a new norovirus strain may be contributing to the current jump in cases. For many years, most infections were linked to the strain GII.4. Now another strain, GII.17, has become dominant, responsible for around 75 percent of outbreaks during the 2024–2025 season, up from about 10 percent during 2022–2023.

What to Do if You Get Sick With Norovirus?

There is no specific treatment for norovirus, as Cleveland Clinic explains. The infection needs to run its course. Staying well-hydrated, resting, and choosing mild, easy-to-digest foods can help ease symptoms. Seek medical care if you cannot keep fluids down or if your symptoms continue beyond three days.

To prevent spreading the virus, the CDC advises avoiding food preparation or caring for others until at least 48 hours after symptoms stop.

The World Health Organization (WHO) issued its first-ever recommendation endorsing GLP-1 medications as part of a long term strategy to manage obesity in adults. Earlier, in the guidance to deal with obesity, the main focus was given to diet and lifestyle changes. Thus, this is a big shift from how the UN agency has traditionally approached obesity treatment.

Until now, WHO guidelines only focused on lifestyle changes including physical activity and diet. The new recommendation acknowledges that medication can play a supportive role when combined with counseling on healthy eating and regular exercise.

Published in the Journal of the American Medical Association (JAMA), the guideline describes long-term use as continuous treatment for at least six months. In its note, WHO called obesity a “chronic, relapsing disease” that affects more than one billion people worldwide and contributes substantially to illness, early death, and economic strain on health systems. GLP-1 therapies, the organization wrote, offer “clinically meaningful weight loss and broad metabolic benefits” when used appropriately.

How Do GLP-1 Drugs Work?

GLP-1 drugs mimic the action of the natural hormone GLP-1 to regulate blood sugar and promote weight loss. They work by increasing insulin release in a glucose-dependent manner, decreasing the liver's production of glucagon, and slowing down the emptying of the stomach, which helps lower blood sugar levels after a meal. They also act on the brain to suppress appetite and increase feelings of fullness, leading to reduced calorie intake.

In people with type 2 diabetes, notes Harvard Health, the body's cells are resistant to the effects of insulin and body does not produce enough insulin, or both. This is when GLP-1 agonists stimulate pancreas to release insulin and suppress the release of another hormone called glucagon.

These drugs also act in the brain to reduce hunger and act on the stomach to delay emptying, so you feel full for a longer time. These effects can lead to weight loss, which can be an important part of managing diabetes.

Why WHO’s Guidance Matters

In September, WHO added GLP-1 drugs to its list of essential medicines, but only for treating diabetes, not for obesity alone. The new guideline extends that conversation, offering a more formal stance on their use in obesity management. The recommendations were developed by a committee of experts in obesity, pharmacology, and public health, following requests from several WHO member states. They also align with approvals already granted by regulators like the U.S. Food and Drug Administration.

Obesity: A Global Health Challenge

Obesity is now recognized as one of the most widespread health concerns worldwide, linked to an increased risk of chronic conditions, including cancers, heart disease, and metabolic disorders. Beyond physical health, it also impacts mental well-being and quality of life. With more than a billion people affected globally, the economic burden on healthcare systems continues to grow.

Also Read: Only 1 in 10 People With Obesity Have Access To Popular GLP-1 Weight-Loss Drugs, Says WHO

However, the accessibility still remains a major issue. n the United States, the most widely used medications: Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy, carry list prices exceeding $1,000 per month. Recently, the Trump administration announced agreements with pharmaceutical companies aimed at lowering costs for people paying out of pocket or covered under Medicare or Medicaid.

Every year on December 3, the International Day of Persons with Disabilities (IDPD) is observed. It is a UN day that works towards promoting the rights and well-being of persons with disabilities at every level of society and development, and to raise awareness of the situation of personal with disabilities in all aspects of life.

At the headquarters of the World Health Organization (WHO), IDPD events are organized to educate the public, raise awareness, advocate for political will and resources, and celebrate WHO's achievement.

Who Are Persons With Disabilities?

As per the United Nations Convention on the Rights of Persons with Disabilities or the UNCRPD, persons with disabilities are individuals with long-term physical, mental, intellectual, or sensory impairments that restrict their ability to participate in society on equal terms.

India’s commitment to accessibility stems from Article 9 of the UNCRPD, which mandates equal access to physical spaces, transportation, and services.

Rights of Persons with Disabilities Act, 2016: India’s RPwD Act, 2016, aligns with this definition and adds the term “benchmark disability,” which refers to individuals with at least 40% of a specified disability.

This Act sets accessibility standards for public spaces and digital platforms.

The Act increased reservation for PwDs from 3% to 4% in jobs and 3% to 5% in higher education.

The RPwD Act expanded the list of disabilities from 7 to 21 categories, including conditions like:

• Autism spectrum disorders.
• Acid attack survivors.
• Multiple sclerosis and chronic neurological conditions.

As per the 2011 Census, India is home to 26.8 million persons with disabilities, which means at least 2.21% of its total population. The highest prevalence is observed between the age group of 10 to 19 years. Among them, 20% have mobility impairments, 19% have visual impairment, 19% have hearing impairment, and 8% suffer from multiple disabilities.

International Day of Persons with Disabilities: Theme

This year, the theme is 'Fostering disability-inclusive societies for advancing social progress, while in 2024, the theme was: 'Amplifying the leadership of persons with disabilities for an inclusive and sustainable future'.

International Day of Persons with Disabilities: Origin

This was first established by the United Nations in 1992, to raise awareness and creating inclusive society for all. The aim was to create an inclusive, accessible, and equitable society where no one is left behind.

International Day of Persons with Disabilities: Significance

The main role of this day in observance is to educate people. As more than 1 billion people in the world, which is around 20% of the world population live with some kind of disability. Thus, in such a scenario it is important for people to be sensitive towards their need. This day also helps address and solve the barriers faced by people living with disabilities, which include:

Limited access to education and employment

Inaccessible public spaces and transportation

Social stigma and discrimination

Insufficient healthcare and rehabilitation services

Lack of assistive technologies and accessible digital platforms